Suchergebnisse - "Julián Gomara, Ana Belén"

PubPharm (6)

1

Symptomatic gallstone disease : Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study

enthalten in: United European gastroenterology journal | 2024

von Velamazán, R. | López-Guillén, P. | Martínez-Domínguez, S. | +31

2

IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY)

enthalten in: Gastroenterologia y hepatologia | 2024

von Deza, D. | Julián Gomara, A. | Biota, E. | +26

3

Symptomatic gallstone disease : Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study

enthalten in: United European Gastroenterology Journal | 2024

von Velamazán, R. | López‐Guillén, P. | Martínez‐Domínguez, S. | +31

4

A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)

enthalten in: Gastroenterologia y hepatologia | 2023

von Casas Deza, D. | Julián Gomara, A. | Caudevilla Biota, E. | +32

5

Liver Disease Undernutrition Screening Tool Questionnaire Predicts Decompensation and Mortality in Cirrhotic Outpatients with Portal Hypertension

enthalten in: Nutrients | 2023

von Casas-Deza, D. | Bernal-Monterde, V. | Betoré-Glaria, E. | +6

6

Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes

enthalten in: PloS one | 2021

von Casas-Deza, D. | Bernal-Monterde, V. | Aranda-Alonso, A. | +4

1
[1]